All Posts

Initiative to Map the Cholangiocarcinoma (CCA) Landscape in Europe Will Help Improve Patient Outcomes
Scientists advocate for education programs to raise awareness and improve early diagnosis, survival, and quality of life of CCA patients…

9th Annual Cholangiocarcinoma Foundation Conference features expert speakers, 40 poster presentations from around the world
The 9th Annual Cholangiocarcinoma Foundation Conference begins on Wednesday, Feb. 23rd, and takes place at the Salt Palace Convention Center.…

Letter to the editor: Learn about bile duct cancer
February is Cholangiocarcinoma Awareness Month. Never heard of cholangiocarcinoma? You're not alone. Also known as bile duct cancer, this devastating…

Five for Friday – 5 ways you can put your advocacy to work for World CCA Day
Home / Blog / [wpbb post:title] World CCA Day is an international effort to raise much-needed awareness of bile duct…

Webinar: Elevating Precision Medicine to the Forefront of Every Cancer Journey to Deliver the Right Medicine to the Right Patient
Cancer behaves differently in each person, and there is no one-size-fits-all treatment. Precision medicine makes cancer diagnosis more accurate and…
Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation
Study Name Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation ClinicalTrials.gov…

Susan Harton
Beloved wife, daughter, sister, and friend, Susan Harton's love of life did not come to an end with her death. Susan…

Five for Friday – 5 Cholangiocarcinoma Educational Videos
Home / Blog / [wpbb post:title] Happy Cholangiocarcinoma Awareness Month! The Foundation co-founded the steering committee of the Global Cholangiocarcinoma…
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Study Name Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations ClinicalTrials.gov Identifier (if applicable) NCT04579380 Clinical…
This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a KRAS G12C mutation.
Study Name This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in…